Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. [L'application topique de médicaments anti-fibrinolytiques pour la chirurgie cardiaque avec circulation extra-corporelle : analyse méthodique et méta-analyse.] [English, French abstract] （打开新窗口）

Abrishami A, Chung F, Wong J.

来源‎: Can J Anaesth 2009;56(3):202-12.

检索‎: PubMed 19247741

DOI码‎: 10.1007/s12630-008-9038-x

https://www.ncbi.nlm.nih.gov/pubmed/19247741 （打开新窗口）

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation. （打开新窗口）

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

来源‎: Heart Lung Circ 2012;21(11):706-10.

检索‎: PubMed 22842057

DOI码‎: 10.1016/j.hlc.2012.06.016

https://www.ncbi.nlm.nih.gov/pubmed/22842057 （打开新窗口）

Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. （打开新窗口）

Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L.

来源‎: J Cardiothorac Surg 2009;4:25.

检索‎: PubMed 19538741

DOI码‎: 10.1186/1749-8090-4-25

https://www.ncbi.nlm.nih.gov/pubmed/19538741 （打开新窗口）

Current status of pharmacologic therapies in patient blood management. （打开新窗口）

Goodnough LT, Shander A.

来源‎: Anesth Analg 2013;116(1):15-34.

检索‎: PubMed 23223098

DOI码‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098 （打开新窗口）

The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. （打开新窗口）

Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.

来源‎: Anesth Analg 2009;109(1):15-24.

检索‎: PubMed 19535691

DOI码‎: 10.1213/ane.0b013e3181a40b5d

https://www.ncbi.nlm.nih.gov/pubmed/19535691 （打开新窗口）

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. （打开新窗口）

Howell N, Senanayake E, Freemantle N, Pagano D.

来源‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

检索‎: PubMed 22889481

DOI码‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 （打开新窗口）

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. （打开新窗口）

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.

来源‎: Anesth Analg 2010;110(1):21-9.

检索‎: PubMed 19910626

DOI码‎: 10.1213/ANE.0b013e3181c0ea6d

https://www.ncbi.nlm.nih.gov/pubmed/19910626 （打开新窗口）

Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion. （打开新窗口）

Mansouri M, Attary M, Bagheri K, Massoumi G, Ghavami B.

来源‎: Interact Cardiovasc Thorac Surg 2012;15(1):23-7.

检索‎: PubMed 22514257

DOI码‎: 10.1093/icvts/ivs114

https://www.ncbi.nlm.nih.gov/pubmed/22514257 （打开新窗口）

A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. （打开新窗口）

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, Angelini GD.

来源‎: J Thorac Cardiovasc Surg 2006;132(3):475-80, 480.e1-8.

检索‎: PubMed 16935098

DOI码‎: 10.1016/j.jtcvs.2006.01.064

https://www.ncbi.nlm.nih.gov/pubmed/16935098 （打开新窗口）

Tranexamic acid in patients undergoing coronary-artery surgery. （打开新窗口）

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

来源‎: N Engl J Med 2017;376(2):136-48.

检索‎: PubMed 27774838

DOI码‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 （打开新窗口）

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. （打开新窗口）

Nurözler F, Kutlu T, Küçük G.

来源‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

检索‎: PubMed 18984759

DOI码‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 （打开新窗口）

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. （打开新窗口）

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

来源‎: JAMA Surg 2013;148(6):538-47.

检索‎: PubMed 23426385

DOI码‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 （打开新窗口）

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. （打开新窗口）

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

来源‎: JAMA. 2022;328(4):336-47.

检索‎: PubMed 35881121

DOI码‎:  10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ （打开新窗口）

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. （打开新窗口）

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

来源‎: Anesth Analg 2012;115(2):239-43.

检索‎: PubMed 21737704

DOI码‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 （打开新窗口）

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. （打开新窗口）

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

来源‎: Ann Thorac Surg 2010;89(5):1489-95.

检索‎: PubMed 20417766

DOI码‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 （打开新窗口）

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. （打开新窗口）

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

来源‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

检索‎: PubMed 20067988

DOI码‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 （打开新窗口）

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? （打开新窗口）

Ballen J, Raabe M, Muirhead B.

来源‎: Can J Anaesth 2006;53(4):353-6.

检索‎: PubMed 16575032

DOI码‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 （打开新窗口）

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. （打开新窗口）

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

来源‎: Transfusion 2013;53(4):798-804.

检索‎: PubMed 22845023

DOI码‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 （打开新窗口）

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. （打开新窗口）

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

来源‎: Ann Thorac Surg 2008;85(3):836-44.

检索‎: PubMed 18291152

DOI码‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 （打开新窗口）

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. （打开新窗口）

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

来源‎: Can J Cardiol 2011;27(6):869.e7-8.

检索‎: PubMed 21983113

DOI码‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 （打开新窗口）

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. （打开新窗口）

Flynn BC, Steiner ME, Mazzeffi M

来源‎: Anesthesiology. 2023 1;139(2):197-210.

检索‎: PubMed 37155359

DOI码‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ （打开新窗口）

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. （打开新窗口）

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

来源‎: Circulation 2009;120(1):21-7.

检索‎: PubMed 19546387

DOI码‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 （打开新窗口）

Intraoperative use of recombinant activated factor VII during complex aortic surgery. （打开新窗口）

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

来源‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

检索‎: PubMed 22285329

DOI码‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 （打开新窗口）

Off-label use of recombinant human factor VIIa. （打开新窗口）

Goodnough LT, Levy JH.

来源‎: Ann Thorac Surg 2014;98(2):393-5.

检索‎: PubMed 25087781

DOI码‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 （打开新窗口）

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). （打开新窗口）

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

来源‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

检索‎: PubMed 21550261

DOI码‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 （打开新窗口）

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. （打开新窗口）

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

来源‎: Circulation 2008;118(4):331-8.

检索‎: PubMed 18606914

DOI码‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 （打开新窗口）

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. （打开新窗口）

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

来源‎: J Vasc Surg 2011;53(4):1032-7.

检索‎: PubMed 21215579

DOI码‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 （打开新窗口）

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. （打开新窗口）

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

来源‎: Transfus Med Hemother 2012;39(2):139-50.

检索‎: PubMed 22670132

DOI码‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 （打开新窗口）

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. （打开新窗口）

Lehr EJ, Alford TJ, Wang SH.

来源‎: Heart Surg Forum 2010;13(5):E275-9.

检索‎: PubMed 20961825

DOI码‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 （打开新窗口）

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. （打开新窗口）

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

来源‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

检索‎: PubMed 18948033

DOI码‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 （打开新窗口）

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. （打开新窗口）

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

来源‎: Drugs R D 2015;15(2):187-94.

检索‎: PubMed 25862216

DOI码‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 （打开新窗口）

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. （打开新窗口）

Tanaka KA, Li P, McHugh SM, Subramaniam K.

来源‎: A A Case Rep 2015;5(1):3-5.

检索‎: PubMed 26125690

DOI码‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 （打开新窗口）

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). （打开新窗口）

Tanaka KA, Waly AA, Cooper WA, Levy JH.

来源‎: Anesthesiology 2003;98(6):1513-5.

检索‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 （打开新窗口）

Recombinant activated factor VII in cardiac surgery: a systematic review. （打开新窗口）

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

来源‎: Ann Thorac Surg 2007;83(2):707-14.

检索‎: PubMed 17258029

DOI码‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 （打开新窗口）

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. （打开新窗口）

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

来源‎: Transfusion 2014;54(5):1348-57.

检索‎: PubMed 24898456

DOI码‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 （打开新窗口）

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. （打开新窗口）

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

来源‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

检索‎: PubMed 22623627

DOI码‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 （打开新窗口）

Reducing blood transfusion in aortic surgery: a novel approach. （打开新窗口）

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

来源‎: Ann Thorac Surg 2019;108(5):1369-75.

检索‎: PubMed 31255616

DOI码‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 （打开新窗口）

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. （打开新窗口）

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

来源‎: Ann Thorac Surg 2009;88(5):1666-8.

检索‎: PubMed 19853132

DOI码‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 （打开新窗口）

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. （打开新窗口）

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

来源‎: Crit Care 2016;20:5.

检索‎: PubMed 26738468

DOI码‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 （打开新窗口）

Bloodless orthotopic heart transplantation in a Jehovah's Witness. （打开新窗口）

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

来源‎: A A Case Rep 2015;4(10):140-2.

检索‎: PubMed 25974419

DOI码‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 （打开新窗口）

State of the art - how I manage coagulopathy in cardiac surgery patients. （打开新窗口）

Davidson S.

来源‎: Br J Haematol 2014;164(6):779-89.

检索‎: PubMed 24450971

DOI码‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 （打开新窗口）

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. （打开新窗口）

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

来源‎: Anesthesiology 2011;115(6):1179-91.

检索‎: PubMed 21970887

DOI码‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 （打开新窗口）

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. （打开新窗口）

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

来源‎: JAMA Netw Open 2021;4(4):e213936.

检索‎: PubMed 33792729

DOI码‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 （打开新窗口）

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. （打开新窗口）

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

来源‎: Thromb Haemost 2009;102(1):137-44.

检索‎: PubMed 19572078

DOI码‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 （打开新窗口）

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. （打开新窗口）

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

来源‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

检索‎: PubMed 23410777

DOI码‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 （打开新窗口）

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. （打开新窗口）

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

来源‎: Anesthesiology 2013;118(1):40-50.

检索‎: PubMed 23249928

DOI码‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 （打开新窗口）

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. （打开新窗口）

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

来源‎: J Am Heart Assoc 2015;4(6):e002066.

检索‎: PubMed 26037084

DOI码‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 （打开新窗口）

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). （打开新窗口）

Ranucci M, Baryshnikova E.

来源‎: Br J Anaesth 2016;116(5):618-23.

检索‎: PubMed 26893405

DOI码‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 （打开新窗口）

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. （打开新窗口）

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

来源‎: Can J Anaesth 2012;59(3):299-303.

检索‎: PubMed 22161243

DOI码‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 （打开新窗口）

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. （打开新窗口）

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

来源‎: Ann Thorac Surg 2019;107(4):1275-83.

检索‎: PubMed 30458156

DOI码‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 （打开新窗口）

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. （打开新窗口）

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

来源‎: Anesth Analg 2007;104(4):763-5.

检索‎: PubMed 17377078

DOI码‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 （打开新窗口）

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. （打开新窗口）

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

来源‎: Scand J Clin Lab Invest 2012;72(2):121-8.

检索‎: PubMed 22233480

DOI码‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 （打开新窗口）

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. （打开新窗口）

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

来源‎: Anaesthesia 2010;65(7):688-91.

检索‎: PubMed 20477783

DOI码‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 （打开新窗口）

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. （打开新窗口）

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

来源‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

检索‎: PubMed 18068065

DOI码‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 （打开新窗口）

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. （打开新窗口）

Wademan BH, Galvin SD.

来源‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

检索‎: PubMed 24263581

DOI码‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 （打开新窗口）

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. （打开新窗口）

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

来源‎: Anesth Analg 2010;110(3):702-7.

检索‎: PubMed 20042444

DOI码‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 （打开新窗口）

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. （打开新窗口）

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

来源‎: Ann Surg 2010;251(2):217-28.

检索‎: PubMed 20010084

DOI码‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 （打开新窗口）

A review of topical hemostatic agents for use in cardiac surgery. （打开新窗口）

Barnard J, Millner R.

来源‎: Ann Thorac Surg 2009;88(4):1377-83.

检索‎: PubMed 19766855

DOI码‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 （打开新窗口）

Armentarium of topical hemostatic products in cardiovascular surgery: an update. （打开新窗口）

Forcillo J, Perrault LP.

来源‎: Transfus Apher Sci 2014;50(1):26-31.

检索‎: PubMed 24412443

DOI码‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 （打开新窗口）

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. （打开新窗口）

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

来源‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

检索‎: PubMed 23134676

DOI码‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 （打开新窗口）

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. （打开新窗口）

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

来源‎: Innovations (Phila) 2012;7(4):229-41.

检索‎: PubMed 23123988

DOI码‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 （打开新窗口）

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). （打开新窗口）

Salerno TA, Gaughan C, Suarez M, Panos AL.

来源‎: J Card Surg 2009;24(6):722-4.

检索‎: PubMed 20078720

DOI码‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 （打开新窗口）

Topical haemostatic agents. （打开新窗口）

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

来源‎: Br J Surg 2008;95(10):1197-225.

检索‎: PubMed 18763249

DOI码‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 （打开新窗口）

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. （打开新窗口）

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

来源‎: Transfus Med 2006;16(1):31-9.

检索‎: PubMed 16480437

DOI码‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 （打开新窗口）

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. （打开新窗口）

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

来源‎: Anesthesiology 2011;115(6):1179-91.

检索‎: PubMed 21970887

DOI码‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 （打开新窗口）

Management of hemorrhage in cardiothoracic surgery. （打开新窗口）

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

来源‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

检索‎: PubMed 23910533

DOI码‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 （打开新窗口）

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. （打开新窗口）

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

来源‎: Anesthesiology 2012;117(3):531-47.

检索‎: PubMed 22914710

DOI码‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 （打开新窗口）